The securement and dressing of percutaneous central venous access devices (CVADs) in the paediatric intensive care: a pilot randomised controlled trial
- Conditions
- Central venous access device failure and complication prior to completion of therapyPublic Health - Health service research
- Registration Number
- ACTRN12614001329651
- Lead Sponsor
- Griffith University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
*Patient requires the insertion of a percutaneous CVAD for >24 hours;
*Will remain in admitted to the RCH/LCCH for >24 hours;
* Less than 16 years of age; and
*Parent or legal guardian, and child if developmentally appropriate, gives informed consent.
*Tunnelled, peripherally inserted, dialysis, or implanted CVADs or pulmonary artery catheters;
*Current bloodstream infection;
*CVAD to be inserted through diseased, burned or scarred skin;
*Allergy to study product; and
*Previous study enrolment in this admission to hospital
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method